Teva

METHOTREXATE

  1. Home
  2.  / 
  3. J Code
  4.  / METHOTREXATE – J8610

Manufacturer:

Teva

Name:

METHOTREXATE

HCPCS Code Descriptor:

Methotrexate; oral, 2.5 mg

Category:

J Code

HCPCS:

J8610

NDC(s):

00054-4550-15, 00054-4550-25, 52652-2001-06, 52652-2001-01, 51285-0366-01, 51285-0367-01, 51285-0368-01, 51285-0369-01, 51079-0670-05, 00054-8550-25, 50268-0527-15, 47335-0235-96, 47335-0235-83, 00555-0572-35, 00555-0572-02, 00378-0014-01

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Oral

About:

METHOTREXATE is an Oncology drug manufactured by Teva and administered via the Oral route of administration. The J Code: J8610 is aligned to the drug METHOTREXATE.

Access Pricing and More By Registering

HCPCS Added Date:

1/1/95

HCPCS Effective Date:

8/31/97

HCPCS Short Description:

Methotrexate oral 2.5 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

https://azuritysolutions.com/patients/xatmep/#product

https://www.rasuvo.com/patient-resources/